TSS MEDICAL SRL
EXHIBITOR AT WHX Dubai 2026
HALL South 7 - BOOTH B70
HALL South 7 - BOOTH B70
| Address | Via Bologna, 220 |
| City | 10154 Torino (TO) |
| Country | Italy |
| Phone | +39 011 2473839 |
| info@tssmedical.com | |
| Website | www.algo-care.com |
COMPANY CONTACTS
Alessio Petricca: info@tssmedical.comFOLLOW COMPANY ON
COMPANY KEYWORDS
patch, wound care , post-operative edema, anti-inflammatory device, p.e.m.f.COMPANY PRODUCT GROUPS
Orthopedic & Physiotherapy / RehabilitationDisposables/Wound Care
COMPANY PROFILE
TssMedical, established in Torino in 1998, provides products, services andmedical devices focused on Pain treatments. Over the years, scientific research
and intellectual curiosity have always distinguished the work of TssMedical
enabling the company to develop new and effective wearable medical devices to
promote reparative wound healing and swelling in post-operative applications.
Our focus is on treatment solutions for improving the patients’ quality of life and
this has made Tssmedical a leading company in clinical research and in the
development of biomedical devices.
The company is ISO9001:2015 certified and has obtained the ISO13485:2016
certification in 2018.
Its main products are: Algocare post- op received the CE mark in 2018, a wearable
RF device with small battery to reduce the swelling and local inflammation after
surgery. AlgoCare is a non-invasive medical device that delivers continuous
electromagnetic therapy to restore damaged cells. The applications cover many
post-operative fields in most of the surgery specialties. Algocare products’ range
has started to cover the European, Middle Eastern and Asian market and the
company aims at covering the entire world market in the next years.
Algocare is an easily applicable wearable product and in the future it will be used
both for chronic and for articular therapies.
The company applies the standard ISO13485 for medical devices’ production;
its quality system is based on controls carried out on every single device and
this leads to a considerable reduction of devices’ malfunctionings on the market.



